Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd (GU5.BE) announced earnings for its nine months that Increased, from last year
The company's earnings totaled RMB3.310 billion, or RMB2.036 per share. This compares with RMB3.158 billion, or RMB1.943 per share, last year.
The company's revenue for the period rose 4.3% to RMB61.605 billion from RMB59.060 billion last year.
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd earnings at a glance (GAAP) :
-Earnings: RMB3.310 Bln. vs. RMB3.158 Bln. last year.-EPS: RMB2.036 vs. RMB1.943 last year.-Revenue: RMB61.605 Bln vs. RMB59.060 Bln last year.
For comments and feedback contact: editorial@rttnews.com
May 22, 2026 14:46 ET Minutes of the latest Fed policy session was the highlight of the week along with survey data on the U.S. housing market. In Europe, survey data signaled the trends in the euro area private sector. Further, consumer price inflation data from the U.K. was in focus. In Asia, various economic indicators from China drew attention to the health of the economy.